Table 2. Perceptions of Who is Responsible for Follow-up of Abnormal Screening Result by Cancer Type Among 275 Respondents.
| Responsibility for follow-up | Responsible for notifying patient, No. (%)a | Responsible for managing result follow-up, No. (%)b | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Breast cancer, mammogram | Cervical cancer, Papanicolaou tests | Colorectal cancer | Lung cancer, low-dose computed tomography | Breast cancer, mammogram | Cervical cancer, Papanicolaou tests | Colorectal cancer | Lung cancer, low-dose computed tomography | ||
| Colonoscopy | Stool cards | ||||||||
| PCP | 88 (32.0) | 148 (53.8) | 80 (29.1) | 171 (62.2) | 210 (76.4) | 175 (63.6) | 183 (66.5) | 192 (69.8) | 223 (81.1) |
| Clinician | |||||||||
| Performing test | 92 (33.5) | 179 (65.1) | 232 (84.4) | 103 (37.5) | 93 (33.8) | 101 (36.7) | 179 (65.1) | 173 (62.9) | 96 (34.9) |
| Interpreting test | 195 (70.9) | 3 (1.1) | 31 (11.3) | 1 (0.4) | 21 (7.6) | 132 (48.0) | 4 (1.5) | 19 (6.9) | 23 (8.4) |
Abbreviation: PCP, primary care practitioner.
a
“In your practice, who is usually responsible for notifying a patient about an abnormal result?”
b
“In your practice, whose responsibility is it to manage the follow-up evaluation of an abnormal result to ensure that a patient receives timely follow-up?”